WEIFANG YAXING CHEMICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.1 CNY | -.--% |
|
-1.20% | -29.07% |
| Apr. 30 | Strained Chinese cities struggle to pay home buying subsidies | RE |
| Apr. 29 | Weifang Yaxing Chemical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,452 | 1,461 | 1,638 | 1,752 | 2,136 | 2,241 |
| Enterprise Value (EV) 1 | 2,267 | 2,029 | 2,393 | 2,680 | 2,651 | 3,211 |
| P/E ratio | 460 x | 51.4 x | -64.9 x | 9.1 x | 17.8 x | 289 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.72 x | 0.88 x | 33.2 x | 9.09 x | 2.52 x | 2.72 x |
| EV / Revenue | 1.13 x | 1.23 x | 48.6 x | 13.9 x | 3.13 x | 3.89 x |
| EV / EBITDA | 15 x | 22.2 x | -86.7 x | -92.2 x | 25.8 x | -1,209 x |
| EV / FCF | -14.1 x | 28.1 x | 50.7 x | -9.84 x | -59.8 x | -8.47 x |
| FCF Yield | -7.1% | 3.56% | 1.97% | -10.2% | -1.67% | -11.8% |
| Price to Book | 39.5 x | 22.6 x | 42.2 x | 7.56 x | 3.35 x | 3.48 x |
| Nbr of stocks (in thousands) | 315,594 | 315,594 | 315,594 | 315,594 | 387,709 | 387,709 |
| Reference price 2 | 4.600 | 4.630 | 5.190 | 5.550 | 5.510 | 5.780 |
| Announcement Date | 4/30/19 | 4/28/20 | 4/28/21 | 3/4/22 | 4/19/23 | 4/8/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2,010 | 1,655 | 49.29 | 192.7 | 846.7 | 824.9 |
| EBITDA 1 | 151.2 | 91.36 | -27.6 | -29.07 | 102.6 | -2.656 |
| EBIT 1 | 68.82 | 26.94 | -33.14 | -50.73 | 50.23 | -66.83 |
| Operating Margin | 3.42% | 1.63% | -67.23% | -26.33% | 5.93% | -8.1% |
| Earnings before Tax (EBT) 1 | 3.107 | 29.22 | -25.67 | 193 | 119.1 | 6.682 |
| Net income 1 | 3.107 | 29.22 | -25.67 | 193 | 108.8 | 6.364 |
| Net margin | 0.15% | 1.77% | -52.08% | 100.17% | 12.86% | 0.77% |
| EPS 2 | 0.0100 | 0.0900 | -0.0800 | 0.6100 | 0.3100 | 0.0200 |
| Free Cash Flow 1 | -160.9 | 72.27 | 47.19 | -272.4 | -44.3 | -379.2 |
| FCF margin | -8% | 4.37% | 95.73% | -141.37% | -5.23% | -45.97% |
| FCF Conversion (EBITDA) | - | 79.1% | - | - | - | - |
| FCF Conversion (Net income) | - | 247.35% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/19 | 4/28/20 | 4/28/21 | 3/4/22 | 4/19/23 | 4/8/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 815 | 568 | 756 | 928 | 515 | 970 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 5.392 x | 6.22 x | -27.38 x | -31.94 x | 5.017 x | -365.2 x |
| Free Cash Flow 1 | -161 | 72.3 | 47.2 | -272 | -44.3 | -379 |
| ROE (net income / shareholders' equity) | 8.96% | 57.7% | -49.7% | 143% | 25% | 0.98% |
| ROA (Net income/ Total Assets) | 3.07% | 1.31% | -1.28% | -1.67% | 1.7% | -2.07% |
| Assets 1 | 101.1 | 2,238 | 2,010 | -11,590 | 6,408 | -306.8 |
| Book Value Per Share 2 | 0.1200 | 0.2000 | 0.1200 | 0.7300 | 1.640 | 1.660 |
| Cash Flow per Share 2 | 0.1700 | 0.9900 | 0.0500 | 0.2800 | 0.2000 | 0.1000 |
| Capex 1 | 0.34 | 3.71 | 303 | 223 | 123 | 249 |
| Capex / Sales | 0.02% | 0.22% | 615.57% | 115.53% | 14.56% | 30.13% |
| Announcement Date | 4/30/19 | 4/28/20 | 4/28/21 | 3/4/22 | 4/19/23 | 4/8/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.07% | 220M | |
| +2.56% | 101B | |
| -1.20% | 65.99B | |
| +47.62% | 41.98B | |
| +15.99% | 38.65B | |
| +4.61% | 32.16B | |
| +9.05% | 19.21B | |
| +12.32% | 16.76B | |
| +17.69% | 15.07B | |
| +8.31% | 14.82B |
- Stock Market
- Equities
- 600319 Stock
- Financials Weifang Yaxing Chemical Co., Ltd.
